A meeting of the Strategic Advisory Group of Experts is going to be held in October in connection with the WHO’s approval for emergency use.
Waiting for the WHO’s decision to approve Bharat Biotech’s Covaxin is on. In such a situation, Bharat Biotech is awaiting approval for the much-awaited Emergency Use Authorization (EUA) by the World Health Organization. However, now it seems that the WHO may get the final vaccine by the month of October. In October, a meeting of the Strategic Advisory Group of Experts is going to be held in connection with WHO’s approval for emergency use.Also Read – Kovid cases increased again in Kerala, more than 12 thousand cases were reported in 24 hours, 155 died
This meeting has been fixed for October 5. It is expected that Bharat Biotech’s covaccine can be given the green signal by the World Health Organization. Significantly, it was indicated by the Union Health Ministry that the Covaccine manufactured by Bharat Biotech may soon be approved for emergency use by global health bodies. Also Read – Corona Vaccination: Every fourth person in the country got the corona vaccine, 25% of the population took both doses
According to ANI, the Union Minister of State in the Ministry of Health, Dr. Bharti Praveen Pawar had said that at present the process of submitting documents for approval by the vaccine manufacturer is going on. It is expected that the emergency use of Covaccine will be approved by the WHO soon. Regarding approval, Bharat Biotech says that all the necessary documents have been submitted for emergency approval to Covaccine. Although this is a routine process, there is no need to worry about it. Also Read – Delayed! After all, why is India’s Covaxin having to wait so long for approval? Watch Video to Find Out